Aromatase inhibitors [elektronicky zdroj] : types, mode of action and indications / Jean R. Lamonte, editor.

Externí odkaz: Kolekce e-knih KNAV

Arthralgia and myalgia associated with aromatase inhibitors: frequency and characterization in real-life patients.

Autor: Camejo, Natalia^1,2 ncam3@yahoo.com, Castillo, Cecilia¹, Santana, Diego¹, Argenzio, Lucia¹, Amarillo, Dahiana¹, Herrera, Guadalupe³, Guerrina, Maria¹, Krygier, Gabriel¹

Publikováno v: Ecancermedicalscience. 2024, Vol. 18 Issue 1676-1753, p1-14. 14p.

A prospective study of vitamin D, proinflammatory cytokines, and risk of fragility fractures in women on aromatase inhibitors for breast cancer.

Autor: Liang E; Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA., Beshara M; Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA., Sheng H; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 14263, USA.; Department of Biostatistics, University at Buffalo, Buffalo, NY, USA., Huang XW; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 14263, USA.; Department of Biostatistics, University at Buffalo, Buffalo, NY, USA., Roh JM; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA., Laurent CA; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA., Lee C; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA., Delmerico J; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 14263, USA., Tang L; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 14263, USA., Lo JC; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA., Hong CC; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 14263, USA., Ambrosone CB; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 14263, USA., Kushi LH; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA., Kwan ML; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA., Yao S; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 14263, USA. song.yao@roswellpark.org.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Nov; Vol. 208 (2), pp. 349-358. Date of Electronic Publication: 2024 Jul 08.

Chemical Shift-Encoded MRI of the Lumbar Vertebral Bone Marrow for Detecting Osteoporosis With Low Trabecular Bone Quality in Patients With Breast Cancer Receiving Aromatase Inhibitors.

Autor: Misaka T; Department of Radiology, Kindai University Nara Hospital, Ikoma, Nara, Japan.; Department of Medical Physics and Engineering, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan., Hashimoto Y; Department of Surgery, Tsuji Hospital, Miyakojima-ku, Osaka, Japan., Ashikaga R; Department of Radiology, Kindai University Nara Hospital, Ikoma, Nara, Japan., Ishida T; Department of Medical Physics and Engineering, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.

Publikováno v: Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2024 Oct; Vol. 60 (4), pp. 1379-1389. Date of Electronic Publication: 2024 Jan 04.

Ischaemic cardiotoxicity of aromatase inhibitors in postmenopausal patients with early breast cancer in Denmark: a cohort study of real-world data.

Autor: Lund M; Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark; Department of Clinical Pharmacology, Copenhagen University Hospital-Bispebjerg and Frederiksberg, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Electronic address: mxd@ssi.dk., Corn G; Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark; Statistics and Data Analysis, Copenhagen, Denmark., Jensen MB; Danish Breast Cancer Cooperative Group, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark., Petersen T; Department of Clinical Pharmacology, Copenhagen University Hospital-Bispebjerg and Frederiksberg, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Dalhoff K; Department of Clinical Pharmacology, Copenhagen University Hospital-Bispebjerg and Frederiksberg, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Ejlertsen B; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Danish Breast Cancer Cooperative Group, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark; Department of Clinical Oncology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark., Køber L; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Department of Cardiology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark., Wohlfahrt J; Cancer Epidemiology and Surveillance, Copenhagen, Denmark., Melbye M; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Danish Cancer Institute, Copenhagen, Denmark; K G Jebsen Center for Genetic Epidemiology, Norwegian University of Science and Technology, Norway; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2024 Nov; Vol. 25 (11), pp. 1496-1506.